Effect of NSAIDs on the recurrence of nonmelanoma skin cancer
Open Access
- 8 May 2006
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 119 (3) , 682-686
Abstract
Experimental studies have consistently shown a protective effect of nonsteroidal antiinflammatory drugs (NSAIDs) against nonmelanoma skin cancers (NMSC). However, little human epidemiological research has been done in this regard. We used data from the Skin Cancer Chemoprevention Study to explore the association of NSAID use and with the risk of basal‐cell carcinoma (BCC) and squamous‐cell carcinoma (SCC). 1,805 subjects with a recent history of NMSC were randomized to placebo or 50 mg of daily β‐carotene. Participants were asked about their use of over‐the‐counter and prescription medications at baseline and every 4 months during the trial. Skin follow‐up examinations were scheduled annually with a study dermatologist; confirmed lesions were the endpoints in the study. We used a risk set approach to the analysis of grouped times survival data and unconditional logistic regression to compute odds ratios [ORs] for various exposures to NSAIDs. The use of NSAIDs was reported in over 50% of questionnaires. For BCC, NSAIDs exhibited a weak protective effect in crude analyses, which attenuated markedly after adjustment. For SCC, the use of NSAIDs in the year previous to diagnosis reduced the odds by almost 30% (adjusted OR= 0.71, 95% CI 0.48–1.04). When we accounted for frequency of use, results for BCC were not striking, and there were inconsistent suggestions of an inverse association with SCC. There were some indications of a modest, nonsignificant reduction on the number of BCCs and SCCs with NSAID use. Our data suggest a weak and inconsistent chemopreventive effect of NSAIDs on BCC and SCC.Keywords
This publication has 51 references indexed in Scilit:
- Cyclooxygenase-2 Expression in Murine and Human Nonmelanoma Skin Cancers: Implications for Therapeutic Approaches¶Photochemistry and Photobiology, 2007
- Cyclooxygenase-2 is a possible target of treatment approach in conjunction with photodynamic therapy for various disorders in skin and oral cavityBritish Journal of Dermatology, 2004
- Awareness, knowledge and attitudes to basal cell carcinoma and actinic keratoses among the general public within EuropeJournal of the European Academy of Dermatology and Venereology, 2004
- A Randomized Trial of Aspirin to Prevent Colorectal Adenomas in Patients with Previous Colorectal CancerNew England Journal of Medicine, 2003
- Is Cyclooxygenase-2 Important in Skin Carcinogenesis?Journal of Environmental Pathology, Toxicology and Oncology, 2002
- Long-Term Use of Nonsteroidal Antiinflammatory Drugs and the Risk of Colorectal AdenomasDigestion, 2000
- Photobiology of PhotocarcinogenesisPhotochemistry and Photobiology, 1996
- The protective effect of indomethacin on photocarcinogenesis in hairless miceCancer Letters, 1995
- Monoclonal Antibody Ber EP4 Distinguishes Basal-Cell Carcinoma from Squamous-Cell Carcinoma of the SkinThe American Journal of Dermatopathology, 1993
- Nonsteroidal Antiinflammatory Drugs in Skin Cancer: RevisitedJNCI: Journal of the National Cancer Institute, 1993